Table 6A.
Comparison of high‐cost therapy with 21 day infusions pre‐ and post‐implantation of the CardioMEMS heart failure system
| Years of observation | Real number of vials utilized | Number of vials utilized in case of levosimendan infusion every 21 days | Avoided number of levosimendan vials | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre‐implant (A) | Post‐implant (B) | Pre‐implant (A) | Post‐implant (B) | (B)–(A) | Pre‐implant (A) | Post‐implant (B) | (B)–(A) | Pre‐implant (A) | Post‐implant (B) | (B)–(A) |
| 2 | 2 | 3 | 6 | 3 | 3 | 40 | 37 | 0 | 34 | 34 |
| 3 | 3 | 0 | 5 | 5 | 0 | 53 | 53 | 0 | 48 | 48 |
| 0 | 0 | 0 | 3 | 3 | 0 | 8 | 8 | 0 | 5 | 5 |
| 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 0 | 1 | 1 | 19 | 19 | 0 | 18 | 18 | |
| 3 | 15 | 12 | 3 | 120 | 117 | 0 | 105 | 105 | ||
The mean of the LION‐HEART study strategy (infusions every 15 days) and the Ortis et al. (infusions every 28 days).